LISA CANDELARIA: Open Payments
NPI 1649671918 · RIO RANCHO, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 3 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
| Lilly USA, LLC | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Abbott Laboratories | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Omnipod, CAPLYTA, MOUNJARO, INGREZZA, FREESTYLE LIBRE 3, Veozah, Dexcom G6 Transmitter, PREVNAR 20.
Industry payments across NM — which companies pay providers there.
